New study seeks best blood clot treatment for cancer patients with low platelets

NCT ID NCT05255003

Recruiting now Knowledge-focused Sponsor: Tzu-Fei Wang Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at the best way to treat blood clots in cancer patients who also have low platelet counts, which raises bleeding risk. Researchers will compare two approaches: full-dose blood thinners with platelet transfusions versus a reduced dose without transfusions. The goal is to see if a larger study is possible, not to find a cure. About 50 adults with active cancer and a recent blood clot will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACTIVE MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer thrombocytopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER-ASSOCIATED THROMBOSIS THROMBOCYTOPENIA

Contacts and locations

Locations

Niagara Health - St. Catharines Site
RECRUITING

Saint Catharines, Ontario, Canada
The Ottawa Hospital
RECRUITING

Ottawa, Ontario, K1H 8L6, Canada
University of Alberta
WITHDRAWN

Edmonton, Alberta, Canada
Windsor Regional Hospital
RECRUITING

Windsor, Ontario, N8W 1L9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.